|
US7569342B2
(en)
|
1997-12-10 |
2009-08-04 |
Sierra Molecular Corp. |
Removal of molecular assay interferences
|
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
|
CA2802143C
(en)
|
2003-01-14 |
2018-06-19 |
Dana-Farber Cancer Institute |
Sparc encoding polynucleotide as a cancer therapy sensitizer
|
|
WO2005059109A2
(en)
*
|
2003-12-15 |
2005-06-30 |
The Regents Of The University Of California |
Molecular signature of the pten tumor suppressor
|
|
EP2299266A1
(en)
*
|
2003-12-19 |
2011-03-23 |
The Regents of the University of California |
Methods and materials for assessing prostate cancer therapies
|
|
NZ550102A
(en)
*
|
2004-02-24 |
2010-10-29 |
Univ California |
Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
|
|
CA2585719A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Schering Corporation |
Tumor association of mdl-1 and methods
|
|
AU2006241235B2
(en)
*
|
2005-04-22 |
2012-04-05 |
Eisai, Inc. |
Antibodies with immune effector activity and that internalize in endosialin-positive cells
|
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
WO2006128063A2
(en)
*
|
2005-05-25 |
2006-11-30 |
Irm Llc |
Methods and compositions for inhibiting glioma growth
|
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
|
US20070021365A1
(en)
*
|
2005-06-21 |
2007-01-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto
|
|
US20100119445A1
(en)
|
2005-07-21 |
2010-05-13 |
N.V. Organon |
Plexin d1 as a target for tumor diagnosis and therapy
|
|
EP1937831B1
(en)
*
|
2005-09-27 |
2012-08-01 |
University of Saskatchewan |
Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis
|
|
WO2007107774A2
(en)
*
|
2006-03-22 |
2007-09-27 |
Cartela R & D Ab |
Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
|
|
BRPI0709771B1
(pt)
|
2006-03-27 |
2022-01-25 |
The Regents Of The University Of California |
Composto e composição farmacêutica
|
|
NZ596260A
(en)
*
|
2006-03-29 |
2013-05-31 |
Univ California |
Diarylthiohydantoin compounds
|
|
AU2007317753B2
(en)
|
2006-11-09 |
2013-11-07 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Differential gene expression in physiological and pathological angiogenesis
|
|
EP2117591A4
(en)
*
|
2007-01-22 |
2010-11-17 |
Mayo Foundation |
REDUCING TUMOR GROWTH
|
|
RS55447B1
(sr)
|
2007-04-05 |
2017-04-28 |
Morphotek Inc |
Metode za inhibiranje vezivanja endosijalina za ligande
|
|
EA009327B1
(ru)
|
2007-04-27 |
2007-12-28 |
Петр Генриевич ЛОХОВ |
Способ получения противоопухолевой вакцины на основе поверхностных антигенов эндотелиальных клеток
|
|
US12180549B2
(en)
|
2007-07-23 |
2024-12-31 |
The Chinese University Of Hong Kong |
Diagnosing fetal chromosomal aneuploidy using genomic sequencing
|
|
US12054776B2
(en)
|
2007-07-23 |
2024-08-06 |
The Chinese University Of Hong Kong |
Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
|
|
CA2693310C
(en)
|
2007-08-02 |
2018-11-27 |
Arresto Biosciences, Inc. |
Lox and loxl2 inhibitors, antibodies and uses thereof
|
|
TWI469971B
(zh)
|
2007-10-26 |
2015-01-21 |
Univ California |
二芳基乙內醯脲類化合物
|
|
DE102008011850A1
(de)
|
2008-02-29 |
2009-09-03 |
Michael Grzendowski |
Biomarker für die Diagnose von Hirntumor
|
|
EP2373338B1
(en)
|
2008-12-03 |
2017-02-15 |
The Johns Hopkins University |
Annexina2 as immunological target
|
|
US9107935B2
(en)
*
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
|
KR101054952B1
(ko)
*
|
2009-01-22 |
2011-08-05 |
재단법인 한국원자력의학원 |
간암 진단 및 환자 생존기간 예측용 마커인 ｕｑｃｒｈ, 그를 포함하는 키트 및 상기 마커를 이용한 간암 환자 생존기간 예측
|
|
ES2363358B1
(es)
*
|
2009-04-03 |
2012-06-21 |
FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON (Titular al |
Agentes terapéuticos para el tratamiento de enfermedades asociadas con una proliferación celular indeseable.
|
|
US20100260769A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Morphotek, Inc. |
Endosialin binding molecules
|
|
CA2771702A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Gilead Biologics, Inc. |
Catalytic domains from lysyl oxidase and loxl2
|
|
MX2012002271A
(es)
*
|
2009-08-21 |
2012-07-20 |
Gilead Biologics Inc |
Metodos y composiciones terapeuticas.
|
|
WO2011022670A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
In vivo screening assays
|
|
RU2012110580A
(ru)
*
|
2009-08-21 |
2013-09-27 |
Джилид Байолоджикс, Инк. |
Способы скрининга in vivo
|
|
US20110207144A1
(en)
*
|
2009-08-21 |
2011-08-25 |
Derek Marshall |
In vitro screening assays
|
|
BR112012019693A2
(pt)
|
2010-02-04 |
2017-06-20 |
Gilead Biologics Inc |
anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
|
|
EP3124481B1
(en)
|
2010-02-16 |
2018-03-28 |
Aragon Pharmaceuticals, Inc. |
Androgen receptor modulators and uses thereof
|
|
EP2371860A1
(en)
*
|
2010-04-05 |
2011-10-05 |
Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron |
Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
|
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
|
US9892230B2
(en)
|
2012-03-08 |
2018-02-13 |
The Chinese University Of Hong Kong |
Size-based analysis of fetal or tumor DNA fraction in plasma
|
|
WO2014052237A1
(en)
|
2012-09-26 |
2014-04-03 |
Aragon Pharmaceuticals, Inc. |
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
|
|
EP2945628B1
(en)
|
2013-01-15 |
2020-04-15 |
Aragon Pharmaceuticals, Inc. |
Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer
|
|
KR101727026B1
(ko)
*
|
2014-03-06 |
2017-04-17 |
(주)노바셀테크놀로지 |
신규 신경교종의 바이오마커 및 그의 용도
|
|
KR101644599B1
(ko)
|
2014-10-14 |
2016-08-16 |
연세대학교 산학협력단 |
미토콘드리아 단백질 uqcrb 관련 질환 유전자발현 세포 구축 및 이를 활용한 uqcrb 기능조절 활성평가계 구축
|
|
US10364467B2
(en)
|
2015-01-13 |
2019-07-30 |
The Chinese University Of Hong Kong |
Using size and number aberrations in plasma DNA for detecting cancer
|
|
ES2850048T3
(es)
*
|
2015-02-16 |
2021-08-25 |
Xintela Ab |
Detección y tratamiento de tumores malignos en el SNC
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
KR20240096623A
(ko)
|
2017-10-16 |
2024-06-26 |
아라곤 파마슈티컬스, 인코포레이티드 |
비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
|
|
CN110687236B
(zh)
*
|
2019-10-30 |
2022-05-17 |
陕西师范大学 |
基于iTRAQ标记蛋白评价肉类冻融程度的方法
|